Replies to post #16223 on NDT Pharmaceuticals Inc (NDTP)

[imnot6]

I don't understand the "we all had dreams of big money" thing. Let's say you had a million shares at .005 per share, half a cent. That's 1mm times .005 = $5,000, not exactly a big stake as stock investments go. The 'dream" is that for whatever reason - because the individual shares are "cheap?" - the shares would jump to ten cents or a dollar, which would be 20X or 200X the initial half-cent share price.

OK, so now there's a 1000:1 reverse split. Your million shares at .005pps are now 1000 shares at $5 per share. Same $5000 value as before, same percentage of shares outstanding, which also shrunk 1000:1. If you expected the 20-200X jump before, why is it suddenly unrealistic now - because a jump to $100 or $1000/share is obviously ridiculous? The dollars involved are the same.

If you agree with the math, then I guess the "dreams" were of taking advantage of a momo-driven, irrationally-exhuberant crowd of fools spiking the price, like many manipulated pink-sheet flashes in the pan? Mike, for all his hyperventilating truth-stretching ("look! The price has jumped from sub-penny to dollars!") has been touting what he thinks will be a real company with real profits. IF that comes to pass, those multiples are no less likely now than before.

[Ecomike]

Kajun, nothing target wise has changed, .10/share pre split is the same as $100/share post split. Which for a biotech with these assets and business plan is still the target. In fact, it may be way easier to down now.

It is market cap that matters, not share price.

The entire float is only 290,000 shares now and with an uplist to Nasdaq that I expect, and no new shares in the float for a year this stock can easily scream all the way to $100/share if they do the $40 Mil cash raise, Underwritten offering Biotech uplist to Nasdaq I expect.

I am more sure of of it now, post R/S than I was before.

Folks putting in $40 Mil in cash, locked up for 12 months, are going eat the float and run it to $100/share IMHO.

And the Company would have 40 Mil in cash, and the Biotech assets that I believe can see a Billion dollar market cap.

Look at the Moderna Biotech market cap, it is Billions, with no revenue.

MILVD could have massive drink line revenue this year, with PepsiCo being the Infrastructure, plus Licensed drug delivery platform licenses to folks like Novartis and Moderna and many others for Nano Delivery Tech to deliver pharmaceuticals to the Brain, since they go where drug has gone before by crossing the BBB-Blood Brain Barrier.

Read this!!

https://ccabiotech.blogspot.com/p/members.html

https://ccabiotech.blogspot.com

https://ccabiotech.blogspot.com/home

http://grantome.com/grant/NIH/R01-NS069629-05
Dr Cohen Grants TBI Huge find!!!

https://www.researchgate.net/publication/322275261_Dietary_therapy_restores_glutamatergic_input_to_orexinhypocretin_neurons_after_traumatic_brain_injury_in_mice

It documents brain self repair using Food grade, purified Food ingredients by delivering the nutrients across the BBB to the brain using MILVD/CCA type of Nano particle complexes, like Liposomes.

I have connected Dr. Cohen to one of the Major MILVD/CCA, LLC shareholders!!!! We Know Dr. Michael Fountain was a cofounder and early pioneer in this effort going back 13 years ago at the Univ Of So. Florida, and assigned a 2016 Patent to the firm.

The lights go on any day now. Do not sell your shares for chump change.

Think about how folks putting $40 Mil in cash into a firm like this are going to act. They will either sit at the bid and wait for us to sell for a short while and / or slowly eat the ask for weeks or months until all the weak hands are out, then Boom they run it to $100/share and sell the float to get back their $40 Mil dollars selling the float shares to Nasdaq and Biotech Index funds desperate for shares, when there are only 290,000 shares in the float to go around. It is supply and demand!!!!

WE own the supply, this is no time to quit!!!